[HTML][HTML] Interleukin-33/serum stimulation-2 pathway: Regulatory mechanisms and emerging implications in immune and inflammatory diseases

P He, M Wu, L Zheng, Y Duan, Q Fan, X Zhu… - Cytokine & Growth Factor …, 2024 - Elsevier
Abstract Interleukin (IL)− 33, a nuclear factor and pleiotropic cytokine of the IL-1 family, is
gaining attention owing to its important role in chronic inflammatory and autoimmune …

Newborn screening for high-risk congenital heart disease by dried blood spot biomarker analysis

H Clausen, E Friberg, K Lannering, A Koivu… - JAMA Network …, 2024 - jamanetwork.com
Importance Congenital heart disease (CHD) is the most common human organ
malformation, affecting approximately 1 of 125 newborns globally. Objectives Assessing the …

Cellular and Molecular Mechanisms Activated by a Left Ventricular Assist Device

A Galeone, C Buccoliero, B Barile, GP Nicchia… - International Journal of …, 2023 - mdpi.com
Left ventricular assist devices (LVADs) represent the final treatment for patients with end-
stage heart failure (HF) not eligible for transplantation. Although LVAD design has been …

[HTML][HTML] Interleukin-33 and Obesity-Related Inflammation and Cancer

C Kowitt, Q Zhang - Encyclopedia, 2024 - mdpi.com
Interleukin-33 (IL-33) is a cytokine belonging to the IL-1 family. It is primarily associated with
type 2 immune responses. It interacts with a receptor complex on immune cells in reaction to …

Heart transplantation and biomarkers: a review about their usefulness in clinical practice

L Martini, GE Mandoli, MC Pastore… - Frontiers in …, 2024 - frontiersin.org
Advanced heart failure (AdvHF) can only be treated definitively by heart transplantation
(HTx), yet problems such right ventricle dysfunction (RVD), rejection, cardiac allograft …

Ten-Year Experience with Endomyocardial Biopsy after Orthotopic Heart Transplantation: Comparison between Trans-Jugular and Trans-Femoral Approach

A Galeone, A Bernabei, G Pesarini… - Journal of …, 2024 - mdpi.com
Background: Endomyocardial biopsy (EMB) is considered the gold standard for monitoring
allograft rejection after heart transplantation. EMB is an invasive procedure that may be …

IL-33: Friend or foe in transplantation?

GF Hassan, LS Cohen, J Alexander-Brett - The Journal of Heart and Lung …, 2024 - Elsevier
Several reports have highlighted the dichotomous nature of the IL-33 system in cardiac and
lung disease, where this cytokine can exert both protective effects and drive pro …

[HTML][HTML] Determining the role of IL-33 and ST2 in hypertension and vascular dysfunction

B Saju - 2024 - theses.gla.ac.uk
Cardiovascular disease (CVD) has long been the leading cause of global morbidity and
mortality, largely due to deaths caused by stroke, heart failure (HF), hypertensive heart …

[引用][C] NetwmorAklOpen.

H Clausen, E Friberg, K Lannering, A Koivu